Calcium channel blockers and cardiac surgery

Area of Science:

• Cardiology
• Pharmacology

Background:

• Calcium channel blockers (CCBs) are crucial in managing cardiovascular diseases.
• They inhibit calcium ion influx, leading to vasodilation and negative inotropic, chronotropic, and dromotropic effects.

Purpose of the Study:

• To review the role and applications of calcium channel blockers in cardiovascular pharmacotherapy.
• To discuss their efficacy, adverse effects, and interactions, particularly in perioperative settings.

Main Methods:

• Review of existing literature on calcium channel blocker mechanisms, indications, and contraindications.
• Analysis of clinical data regarding adverse effects and drug interactions.

Main Results:

• CCBs are indicated for angina, hypertension, and supraventricular arrhythmias.
• Use in hypertrophic cardiomyopathy, heart failure, and pulmonary hypertension is investigational.
• They are increasingly used in cardiac surgery, effective for perioperative coronary spasm and post-surgical atrial arrhythmias (e.g., Verapamil).
• Interactions with anesthetics are generally not clinically significant.
• Continuation of CCB therapy until surgery is usually safe.

Conclusions:

• Calcium channel blockers are versatile agents in cardiovascular medicine with expanding roles.
• Careful patient selection and monitoring are essential to mitigate risks, especially in those with pre-existing cardiac conditions.
• Further research is needed on their interactions with cardioplegia and hypothermia.